Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Acadesine

EU orphan designation number: EU/3/05/280   
Active ingredient: Acadesine
Indication: Treatment of B-cell chronic lymphocytic leukemia (B-CLL)
Sponsor: Advancell - Advanced In Vitro Cell Technologies S.A.
Via Augusta 59, 3rd floor, door 313, E-08006 Barcelona, España

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
31/05/2005 Centralised Orphan - Designation EMEA/OD/010/05 (2005)1659 of 27/05/2005
19/09/2008 Other procedure
05/07/2013 Other procedure